. Characterization of MDA-MB-231, Ishikawa and SKOV3 EVs isolated by ExoGAG. (A) Representative NTA Nanosight NS300 image of isolated MDA-MB-231 EVs (upper panel), Ishikawa EVs (middle panel) and SKOV3 EVs (lower panel) expressed in size (nm) and concentration (particles/ml) (n = 3); (B) Cytometry analysis of MDA-MB-231 EVs resulted in a specific CD81 and CD63 labelling (n = 2); (C) Efficiency of purified EVs, expressed as EVs particles per frame, was found similar in ExoGAG and ultracentrifugation in all three cell lines (upper graph) (n = 3). Protein coprecipitation levels quantified by BCA assay showed a low protein co-precipitation in EVs isolated by ExoGAG compared to those isolated by ultracentrifugation in Ishikawa, SKOV3 and MDA-MB-231 EVs (p = 0.081, p = 0.064, ** p = 0.005, respectively, according to paired T-test; n = 4) (lower graph).
. Characterization of plasma EVs isolated by ultracentrifugation, ExoQuick and ExoSpin. (A) Ultracentrifugation: EVs were collected at high speed ultracentrifugation (100,000 × g, 16 h, 4 °C) in a SW32Ti rotor (Beckman Coulter, Brea, CA, USA) and resuspended in PBS. NTA Nanosight NS300 particle tracking profile of plasma EVs isolated by ultracentrifugation expressed in size (nm) and concentration (particles/ml) resulted in a low efficiency of recovery (left panel); n = 2. Cytometry analysis showed a specific CD9 labelling of EVs purified (right panel) (n = 2); (B) ExoQuick: 50 µL of plasma samples were incubated with 13.4 µL of ExoQuick reagent during 30 min and collected by centrifugation at 3000 × g, 10 min, 4 o C (Eppendorf, Hamburg, Germany). ExoSpin: 50 µL of plasma samples were incubated with 25 µL of ExoSpin reagent for 5min and collected by centrifugation at 16000 × g, 30 min, 4 o C (Eppendorf, Hamburg, Germany). NTA Nanosight NS300 particle tracking profile of plasma EVs isolated by ExoQuick and ExoSpin expressed in size (nm) and concentration (particles/ml) (n = 3) (left panel). Efficiency of purified EVs, expressed as the number of EVs per frame, was higher although comparable in ExoQuick and ExoSpin referred to ExoGAG (n = 3) meanwhile protein co-precipitation levels quantified by BCA assay showed a low co-precipitation in EVs isolated by ExoGAG compared to those isolated by ExoQuick and ExoSpin (**** p < 0.0001 and ** p < 0.0014, respectively, according to paired T-test; n = 4) (right panel). Figure S3 . Efficiency (particles/frame) of EVs purified by ExoGAG in a representative cohort of endometrial cancer patients (n = 8) and healthy controls (n = 8). EVs particles levels were significant higher in patients vs. healthy controls (* p = 0.0148 according to Mann-Whitney U-test).
Figure S4
. Efficiency of ultracentrifugation (16h) to reduce the EVs contain from culture media analysed by NTA Nanosight NS300 and expressed as particles/frame. Complete culture media resulted in a mean of 149.4 particles/frame whereas reduced culture media resulted in 88.85 particles/frame on average (n = 2).
